These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11127360)

  • 21. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
    Jouannic JM; Delahaye S; Fermont L; Le Bidois J; Villain E; Dumez Y; Dommergues M
    Prenat Diagn; 2003 Feb; 23(2):152-6. PubMed ID: 12575024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flecainide: its value and danger.
    Malik R; Ellenbogen KA; Stambler BS; Wood MA
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative Management of Flecainide: A Problem-Based Learning Discussion.
    Acker L; Bova Campbell K; Naglee C; Taicher B; Bronshteyn YS
    A A Pract; 2021 Apr; 15(4):e01443. PubMed ID: 33793430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the use of flecainide acetate in the long-term management of cardiac arrhythmias.
    Wiseman MN; Elstob JE; Camm AJ; Nathan AW
    Pacing Clin Electrophysiol; 1990 Jun; 13(6):767-75. PubMed ID: 1695357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flecainide acetate in the treatment of resistant supraventricular arrhythmias.
    Epstein M; Jardine RM; Obel IW
    S Afr Med J; 1988 Dec; 74(11):559-62. PubMed ID: 3143159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse infiltrative lung disease associated with flecainide. Report of two cases.
    Pesenti S; Lauque D; Daste G; Boulay V; Pujazon MC; Carles P
    Respiration; 2002; 69(2):182-5. PubMed ID: 11961436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute therapy of tachycardic arrhythmias. 1: Anti-arrhythmia agents, supraventricular tachycardia].
    Gonska BD; Rab J
    Fortschr Med; 1995 Feb; 113(6):73-6. PubMed ID: 7721225
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical pharmacology of flecainide].
    Słowiński S; Rutowski J
    Wiad Lek; 1988 Nov; 41(21):1439-43. PubMed ID: 3150637
    [No Abstract]   [Full Text] [Related]  

  • 29. [Flecainide acetate].
    Bordier P; Garrigue S; Clémenty J
    Ann Cardiol Angeiol (Paris); 1996 May; 45(5):263-79. PubMed ID: 8763646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adenosine as an anti-arrhythmia agent].
    Scheininger MJ; Wehling M
    Dtsch Med Wochenschr; 1996 Feb; 121(5):139-40. PubMed ID: 8717198
    [No Abstract]   [Full Text] [Related]  

  • 31. A symposium: Use of flecainide for the treatment of supraventricular arrhythmias. Amsterdam, The Netherlands, August 17, 1991.
    Am J Cardiol; 1992 Aug; 70(5):1A-74A. PubMed ID: 1354936
    [No Abstract]   [Full Text] [Related]  

  • 32. Neonatal complex arrhythmias possibly related to a TTN mutation.
    Evans WN; Acherman RJ; Law IH; Von Bergen NH; Samson RA; Restrepo H
    J Neonatal Perinatal Med; 2017; 10(3):343-346. PubMed ID: 28854511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis, treatment, observation and outcome of fetal supraventricular tachycardia in a twin pregnancy.
    Schiermeier S; van Leeuwen P; Reinhard J; Gronemeyer D; Hatzmann W
    Fetal Diagn Ther; 2008; 24(4):327-30. PubMed ID: 18836269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrocephaly-capillary malformation presenting with fetal arrhythmia.
    Kuint J; Globus O; Ben Simon GJ; Greenberger S
    Pediatr Dermatol; 2012; 29(3):384-6. PubMed ID: 22329570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
    Doki K; Homma M; Kuga K; Aonuma K; Sakai S; Yamaguchi I; Kohda Y
    Eur J Clin Pharmacol; 2007 Oct; 63(10):951-7. PubMed ID: 17665182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flecainide for supraventricular and ventricular arrhythmias in children and young adults.
    Zeigler V; Gillette PC; Ross BA; Ewing L
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):818-20. PubMed ID: 3138905
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug treatment of supraventricular tachycardia.
    Blomström-Lundqvist C
    Heart; 2009 Nov; 95(21):1803-7. PubMed ID: 19828824
    [No Abstract]   [Full Text] [Related]  

  • 39. [Flecainide controlled-release for prevention of atrial fibrillation relapse].
    Simon T; Mary-Krause M; Chatelin A; Thuault M; Jaillon P;
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):109-16. PubMed ID: 16555693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is exercise testing safe in patients treated with flecainide for atrial arrhythmia?
    Blatt CM; Lampert S; Graboys TB
    Am Heart J; 1993 Jul; 126(1):268-9. PubMed ID: 8322688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.